{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:40:43Z","timestamp":1784774443430,"version":"3.55.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.crohns.2013.03.009","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T20:45:16Z","timestamp":1367268316000},"page":"e522-e532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch"],"prefix":"10.1093","volume":"7","author":[{"given":"Lael","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Roggenbuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanir","family":"Zion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhanan","family":"Meirowithz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Ofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Guzner-Gur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Tulchinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2013.03.009_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.gastro.2006.04.030","article-title":"Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease","volume":"131","author":"Dotan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0015","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/ibd.22862","article-title":"Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis","volume":"18","author":"Kaul","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ibd.21046","article-title":"Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior","volume":"16","author":"Rieder","year":"2010","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cgh.2007.03.006","article-title":"A critical evaluation of serologic markers for inflammatory bowel disease","volume":"5","author":"Austin","year":"2007","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0030","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.3748\/wjg.v16.i45.5732","article-title":"Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives","volume":"16","author":"Demirsoy","year":"2010","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00042737-200501000-00015","article-title":"Association of antibodies to exocrine pancreas with subtypes of Crohn's disease","volume":"17","author":"Klebl","year":"2005","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0040","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s10620-005-3056-0","article-title":"Pancreatic autoantibodies in Greek patients with inflammatory bowel disease","volume":"50","author":"Koutroubakis","year":"2005","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.crohns.2013.03.009_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ibd.20778","article-title":"Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2\/CARD15 or TLR4 genotype in a Hungarian IBD cohort","volume":"15","author":"Lakatos","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00365528709089774","article-title":"Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease","volume":"139","author":"Stocker","year":"1987","journal-title":"Scandinavian Journal of Gastroenterology. Supplement"},{"key":"10.1016\/j.crohns.2013.03.009_bb0055","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1136\/gut.2008.162495","article-title":"Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease","volume":"58","author":"Roggenbuck","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2013.03.009_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.autrev.2011.09.004","article-title":"Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies","volume":"11","author":"Bogdanos","year":"2011","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.crohns.2013.03.009_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-230X-12-102","article-title":"Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease","volume":"12","author":"Bogdanos","year":"2012","journal-title":"BMC Gastroenterology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/DCR.0b013e3182417358","article-title":"The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis","volume":"55","author":"Suzuki","year":"2012","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.crohns.2013.03.009_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.gtc.2009.07.002","article-title":"Pouchitis and pouch dysfunction","volume":"38","author":"Wu","year":"2009","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1016\/j.crohns.2013.03.009_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0889-8553(05)70175-8","article-title":"Pouch and pouchitis","volume":"30","author":"Stocchi","year":"2001","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1016\/j.crohns.2013.03.009_bb0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrgastro.2012.58","article-title":"Acute and chronic pouchitis\u2013pathogenesis, diagnosis and treatment","volume":"9","author":"Shen","year":"2012","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0090","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s10620-012-2050-6","article-title":"ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch\u2013anal anastomosis","volume":"57","author":"Coukos","year":"2012","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.crohns.2013.03.009_bb0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cgh.2011.09.016","article-title":"Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch\u2013anal anastomosis","volume":"10","author":"Tyler","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0100","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ibd.20430","article-title":"Comprehensive pouch clinic concept for follow-up of patients after ileal pouch anal anastomosis: report of 3years' experience in a tertiary referral center","volume":"14","author":"Tulchinsky","year":"2008","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/bega.2002.0348","article-title":"Diagnosis and treatment of pouchitis","volume":"17","author":"Gionchetti","year":"2003","journal-title":"Best Practice & Research. Clinical Gastroenterology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0025-6196(12)61634-6","article-title":"Pouchitis after ileal pouch\u2013anal anastomosis: a Pouchitis Disease Activity Index","volume":"69","author":"Sandborn","year":"1994","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.crohns.2013.03.009_bb0115","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ibd.21911","article-title":"Etiology of pouchitis","volume":"18","author":"Landy","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ibd.21106","article-title":"CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system","volume":"16","author":"Dotan","year":"2010","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0125","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.4049\/jimmunol.1103190","article-title":"Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses","volume":"189","author":"Werner","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0130","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2006.108043","article-title":"New serological markers in inflammatory bowel disease are associated with complicated disease behaviour","volume":"56","author":"Ferrante","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2013.03.009_bb0135","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ibd.21239","article-title":"Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis","volume":"16","author":"Lu","year":"2010","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0140","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1521-6918(03)00071-4","article-title":"Probiotics for the treatment of postoperative complications following intestinal surgery","volume":"17","author":"Gionchetti","year":"2003","journal-title":"Best Practice & Research. Clinical Gastroenterology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.mpa.0000160302.40931.7b","article-title":"Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression","volume":"11","author":"Lammers","year":"2005","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gtc.2012.01.007","article-title":"Fecal markers: calprotectin and lactoferrin","volume":"41","author":"Abraham","year":"2012","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1016\/j.crohns.2013.03.009_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/mi.2009.107","article-title":"Diverse regulatory pathways for IgA synthesis in the gut","volume":"2","author":"Suzuki","year":"2009","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0165","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cca.2012.01.005","article-title":"Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, in patients with gluten-sensitive enteropathy: a possible serological trap","volume":"413","author":"Bonaci-Nikolic","year":"2012","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.crohns.2013.03.009_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.autrev.2011.05.014","article-title":"Autoantibody diagnostics in clinical practice","volume":"11","author":"Conrad","year":"2012","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.crohns.2013.03.009_bb0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/gut.2010.233148","article-title":"Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases","volume":"61","author":"Op De Beeck","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2013.03.009_bb0180","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ibd.20661","article-title":"Crohn's disease of the ileal pouch: reality, diagnosis, and management","volume":"15","author":"Shen","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.crohns.2013.03.009_bb0185","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00384-012-1444-4","article-title":"Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch","volume":"27","author":"Tang","year":"2012","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.crohns.2013.03.009_bb0190","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.gassur.2006.02.004","article-title":"Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch\u2013anal anastomosis","volume":"10","author":"Dendrinos","year":"2006","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.crohns.2013.03.009_bb0195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gut.47.4.487","article-title":"Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics","volume":"47","author":"Vasiliauskas","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2013.03.009_bb0200","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/gut.29.12.1639","article-title":"Ulcerative colitis specific cytotoxic IgG-autoantibodies against colonic epithelial cancer cells","volume":"29","author":"Auer","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2013.03.009_bb0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cellimm.2007.02.004","article-title":"Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis","volume":"244","author":"Ebert","year":"2006","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.crohns.2013.03.009_bb0210","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.febslet.2005.02.073","article-title":"Molecular mimicry may contribute to pathogenesis of ulcerative colitis","volume":"579","author":"Kovvali","year":"2005","journal-title":"FEBS Letters"},{"key":"10.1016\/j.crohns.2013.03.009_bb0215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10350-007-9158-3","article-title":"Familial history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis","volume":"51","author":"Melmed","year":"2008","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.crohns.2013.03.009_bb0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature08529","article-title":"Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response","volume":"462","author":"Hase","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.crohns.2013.03.009_bb0225","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.89.4.1189","article-title":"GP-2\/THP gene family encodes self-binding glycosylphosphatidylinositol-anchored proteins in apical secretory compartments of pancreas and kidney","volume":"89","author":"Fukuoka","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/7\/11\/e522\/1187030\/7-11-e522.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T22:05:14Z","timestamp":1503439514000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2013.03.009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1873994613001335"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2013.03.009","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2013.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}